RESEARCHARTICLE 5α-reductase 1 mRNA levels are positively correlated with TRAMP mouse prostate most severe lesion scores AlexanderB.Opoku-Acheampong1,JamieN.Henningson2,AmandaP.Beck3,Brian L.Lindshield1* 1 DepartmentofFood,Nutrition,DieteticsandHealth,KansasStateUniversity,Manhattan,KS,UnitedStatesof America,2 CollegeofVeterinaryMedicine,KansasStateUniversity,Manhattan,KS,UnitedStatesofAmerica, 3 DepartmentofPathology,AlbertEinsteinCollegeofMedicine,Bronx,NY,UnitedStatesofAmerica a1111111111 *[email protected] a1111111111 a1111111111 a1111111111 Abstract a1111111111 Background Thecontributionof5α-reductase1and5α-reductase2toprostatecancerdevelopmentand progressionisnotclearlyunderstood.TRAMPmiceareacommonprostatecancermodel, OPENACCESS inwhich5α-reductase1and5α-reductase2expressionlevels,alongwithprostatelesions Citation:Opoku-AcheampongAB,HenningsonJN, scores,havenotbeeninvestigatedatdifferenttimepointstofurtherunderstandprostate BeckAP,LindshieldBL(2017)5α-reductase1 carcinogenesis. mRNAlevelsarepositivelycorrelatedwithTRAMP mouseprostatemostseverelesionscores.PLoS ONE12(5):e0175874.https://doi.org/10.1371/ Method/Principalfindings journal.pone.0175874 Tothisend,8-,12-,16-,and20-week-oldmaleC57BL/6TRAMPxFVBmiceprostatemost Editor:MohammadSaleem,Universityof severeandmostcommonlesionscores,5α-reductase1and5α-reductase2insituhybrid- MinnesotaHormelInstitute,UNITEDSTATES izationexpression,andKi-67,androgenreceptor,andapoptosisimmunohistochemistry Received:September29,2016 levelsweremeasured.Levelsofthesemarkerswerequantifiedinprostateepithelium, Accepted:March31,2017 hyperplasia,andtumorssections.Micedevelopedlow-tohigh-gradeprostaticintraepithelial neoplasiaat8weeksasthemostsevereandmostcommonlesions,andmoderate-and Published:May11,2017 high-gradeprostaticintraepithelialneoplasiaat12and16weeksasthemostseverelesion Copyright:©2017Opoku-Acheampongetal.This inalllobes.Moderatelydifferentiatedadenocarcinomawasobservedat20weeksinall isanopenaccessarticledistributedunderthe termsoftheCreativeCommonsAttribution lobes.Poorlydifferentiatedcarcinomawasnotobservedinanylobeuntil12-weeks-old.5α- License,whichpermitsunrestricteduse, reductase1and5α-reductase2werenotsignificantlydecreasedintumorscomparedto distribution,andreproductioninanymedium, prostateepitheliumandhyperplasiainallgroups,whileproliferation,apoptosis,andandro- providedtheoriginalauthorandsourceare credited. genreceptorwereeithernotablyorsignificantlydecreasedintumorscomparedwithpros- tateepitheliumandhyperplasiainmostorallgroups.Prostate5αR1levelswerepositively DataAvailabilityStatement:Allrelevantdataare withinthepaperanditsSupportingInformation correlatedwithadjustedprostatemostseverelesionscores. files. Conclusion Funding:ThisworkwassupportedbyNational InstituteofHealth(https://www.nih.gov)COBRE Downregulationofandrogenreceptorand5α-reductase2,alongwithupregulationof5α- EpithelialFunctioninHealth&Disease(NIH-Grant reductase1intumorsmaypromoteprostaticintraepithelialneoplasiaandprostatecancer No:P20-RR017686fromNCRR)andtheJohnson CenterforBasicCancerResearchatKansasState developmentinTRAMPmice. University.Thefundershadnoroleinstudy PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 1/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores design,datacollectionandanalysis,decisionto Introduction publish,orpreparationofthemanuscript. AmongUSmen,prostatecanceristhemostcommonlydiagnosedcancerandthethird-lead- Competinginterests:Theauthorshavedeclared ingcauseofcancerdeath[1].Androgensareprimarilyinvolvedinthedevelopmentandpro- thatnocompetinginterestsexist. gressionofprostatecancer[2].Testosteroneisconvertedbytheisoenzymes5α-reductase1 (5αR1)and5α-reductase2(5αR2)intodihydrotestosteronetoregulatetheprostategland [3,4].Androgensbindtotheandrogenreceptor(AR),withthelatteractingasatranscription factortoregulatetheexpressionofandrogenresponsegenesthatmodulatemanycellular activitiessuchasproliferationandapoptosistocontributetoprostatecancerdevelopmentand progression[5].Inthenormalprostate,5α-reductase2istheprimaryisoenzyme[6]. Manystudies[7–10]althoughnotall[11–13],haveobservedincreased5α-reductase1and/ ordecreased5α-reductase2mRNAexpressionoractivityinprostatecancercomparedwith nonmalignantprostatetissue.Additionally,5α-reductase1and5α-reductase2wereobserved in73%and56%,respectively,ofhumanprostatecancertissues[12].Takentogether,5α- reductasesmaybeinvolvedinprostatecarcinogenesis[14]. Acommonmodelisthetransgenicmousemodel(TRAMP),whichusestheratprostate- specificpromoterprobasintodirecttheexpressionofthesimianvirus40(SV40)largeand smallTantigentotheprostateepitheliumtocausecelltransformation.TRAMPmicedevelop progressiveformsofprostatecancerwithlesionsrangingfrommildprostaticintraepithelial neoplasia(PIN)throughwell-differentiated(WD)adenocarcinoma,toinvasivePDadenocar- cinomawithdistantsitemetastasistopelviclymphnodesandlungs[15,16].InTRAMPmice, thetransgeneisdetectedasearlyas3weeksofage[17],withpathologicalfeaturessimilarto low-gradePINdevelopingasearlyas4–6weeksofage[18].C57BL/6TRAMPxFVBmice developepithelialhyperplasiaby8weeks[19],PINandWDadenocarcinomaby12weeks, andinvasivecarcinomaappearingbetween18–30weeksandmetastasizingintolymphnodes andlungsandoccasionallykidney,boneandadrenalglands[18,20].By30weeksofage, TRAMPmiceonanFVBbackground(TRAMPxFVB)display100%metastasistolungsand lymphnodesalongwithbonemetastasis[16,21]. Inadditiontonotunderstanding5α-reductaselevelsinTRAMPmice,modifiedgrading schemes[22]havenotbeenemployedtoassessthedevelopmentandprogressionofprostate cancerinthesemice.Thus,thisstudywasdesignedtoquantifythecell-typespecificexpression patternsof5αR1and5αR2mRNA,ARandKi-67protein,alongwithapoptoticDNAfragmen- tation,inprostatetissuesectionsof8-,12-,16-,and20-week-oldC57BL/6TRAMPxFVBmice tocharacterizehowtheirlevelsvaryatdifferentagesandstagesofprostatecarcinogenesis.Six- teenweeksisintermediatebetween12and20weekswhenTRAMPmicewouldhavedeveloped PDandinvasivecarcinoma[20].Thesetimepointswereusedpreviouslytostudytheincidence anddistributionofpathologicchangeswithineachlobeofC57BL/6TRAMPxFVBmicepros- tateasafunctionoftime[20].Tothebestofourknowledge,thisstudyisthefirsttograde lesionsandquantify5α-reductaselevelsatdifferentagesinTRAMPmouseprostate. Materialsandmethods Ethicsstatement TheInstitutionalAnimalCareandUseCommittee(IACUC)atKansasStateUniversity approvedallanimalprocedures(protocol2969). Studymiceanddesign Micewerebredasdescribedpreviously[23].MaleC57BL/6TRAMPxFVBmicewereweaned andbeganconsumingAIN-93Gdietat3weeksofagebeforebeingrandomizedto8-(n=5), PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 2/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores 12-(n=8),16-(n=9),and20-(n=12)weekgroups.Micewerecohouseduntil8weeks,and thenindividuallyhoused,monitoreddaily,weighedweekly,andprovidedAIN-93Gdietand wateradlibitum.Micewereterminatedattheirrespectivestudytimepointsbyanesthetizing viaCO inhalationandeuthanizedbyexsanguination.Thegenitourinary(GU)tracts,kidneys, 2 andlungsweredissected,andtheGUtractswereweighed.Iliaclymphnodeswerealsocol- lectedwheneverpossible.Alltissueswerefixedbyimmersionin10%neutralbufferedformalin for48hours,andthenmovedto70%alcoholuntilprocessingintheKansasStateUniversity VeterinaryDiagnosticLaboratory. Histopathology Histologicalprocessingofprostatetissues,sectioning,scoringformostcommonandmost severelesions,andadjustingfordistribution,wereperformedasdescribedpreviously[22,23]. Theanterior,dorsal,lateralandventrallobesofC57BL/6TRAMP×FVBmicewereassigned twogradeseachbetween0–7.Thefirstgradeisthemostseverelesionwithinthelobe[normal prostateasleastsevere(grade0),andPDcarcinomaasmostsevere(grade7)].Thesecond gradeisthemostcommonlesionwithinthelobe[normalprostateasleastcommon(grade0), andPDcarcinomaasmostcommon(grade7)].Themostsevereandmostcommonlesions withinalobewereadjustedfordistribution,eitherasfocal,multifocal,ordiffuse.Withfocal, therearefewerthanthreefociwithinthelobe.Multifocalindicatestherearethreeormorefoci withinthelobe,withlessthan50%ofthelobecontainingthelesionofinterest.Diffuseindi- catesgreaterthan50%ofthelobeisaffected[23].Prostatelesionswerescoredblindlytwiceby aboard-certifiedpathologist(JNH).Selecttissueswerealsoscoredblindlytwicebyaboard- certifiedsecondveterinarypathologist(APB)toensurescoringconsistency.Iliaclymphnodes examinationformetastaseswasdoneasdescribedpreviously[23].Formalin-fixed,paraffin- embeddedprostatetissuesections(4μm)of8-,12-,16-,and20-week-old(n=5)AIN-93G- fedmaleC57BL/6TRAMPxFVBmicewerepreparedforbiomarkerdetection.Mostprostate samplesatthetimeofeuthanasiawerecompletelyobliteratedbytumorandthereforeinmost samples,prostatelobescouldnotbeidentified.Insomeinstances,allfourlobeswerereplaced bytumor. 5α-reductase1and5α-reductase2insituhybridization 5αR1and5αR2accessionsNM175283.3andNM053188.2,respectively,obtainedfrom NationalCenterforBiotechnologyInformation(NCBI)websiteweresubmittedtoAdvanced CellDiagnostics,Inc.,[(ACD),Hayward,CA)]forcustomprobedesignandsynthesisforuse intheirRNAscopeassay.ProstatesectionswerebakedinaFisherScientific(model77)slide warmerpreheatedto55˚Cfor25minutes.Sectionsweredeparaffinizedinxylene,rehydrated in100%ethanol,andair-driedfor5minutesatroomtemperature.Sectionswerethentreated seriallywith:Pre-Treatment1solution(endogenoushydrogenperoxidaseblockwithPretreat 1solutionfor10minutesatroomtemperature);Pre-Treatment2(100–104˚C,25minutes immersioninPretreat2solution);and,Pre-Treatment3(proteasedigestion,40˚Cfor28min- utes);rinseswithdistilledwater(2X)wereperformedaftereachPre-Treatmentstep.Sections werethenhybridizedin5αR1or5αR2probes,withoutacoverslip,at40˚Cfor2hoursina HybEZOven(ACD).Afterwashbuffersteps,signalamplificationfromthehybridizedprobes wereperformedbytheserialapplicationofAmp1,40˚Cfor30minutes(PreAmplifierstep); Amp2,40˚Cfor15minutes(signalenhancerstep);Amp3,40˚Cfor30minutes(amplifier step);Amp4,40˚Cfor15minutes(LabelProbestep);Amp5,ambienttemperaturefor30min- utes,andAmp6,ambienttemperaturefor15minutes(signalamplificationssteps).Wash bufferstepswithWashBuffer(ACD,proprietary)wereperformedaftereachAmpstep. PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 3/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores Horseradishperoxidase(HRP)activitywasthenobservedbytheapplicationof3,30-diamino- benzidine(DAB)for10minutesatambienttemperature.Sectionswerethencounterstained withGill’shematoxylin,dehydratedthroughgradedethanol[95%(1X)and100%(2X)]and xyleneandthenmounted.SectionswerequalitycontrolledforRNAintegritywithanRNA- scopeprobeforcyclophilinB(Mm-Ppib)RNA(positivecontrol)andfornonspecificback- groundwithaprobeforbacterialdapBRNA(negativecontrol).SpecificRNAstainingsignal wasidentifiedasbrown,punctatedots. Immunohistochemistry Androgenreceptor. ProstatesectionswerebakedinaFisherScientificIsotemp(model 281A)vacuumovenpreheatedto60˚Cfor30minutes.Afterbaking,sectionsweredeparaffi- nizedinxyleneandrehydratedusingadecreasingethanolgradient[100%(2X),95%and80% (1X)].Endogenousalkalinephosphatasewasblockedusing3%hydrogenperoxideinmetha- nol.Antigenretrievalwascarriedoutbymicrowavingat540Win10mMTris/1mMEDTA buffer,pH9,fourtimesfor5minutes.Sectionswereblockedwith2.5%normalhorseserum (VectorLaboratories,Inc.,Burlingame,CA)beforeincubationfor1hourat37˚Cwitharabbit polyclonalantibodytoAR(1:50dilution;N-20,sc-816;SantaCruzBiotechnology,SantaCruz, CA).Afterwashing,sectionswereincubatedwithImmPRESS-APanti-rabbitIgG(alkaline phosphatase)polymerdetectionreagent(MP-5401;VectorLaboratories,Inc.,)for30minutes atroomtemperature.ColorsweredevelopedwithaVectorRedalkalinephosphatasesubstrate kit(SK-5100;VectorLaboratories,Inc.,).Slidesweresubsequentlycounterstainedwithhema- toxylin(VectorLaboratories,Inc.,),andprocessedbacktoxylenethroughanincreasingetha- nolgradient[80%and95%(1X),and100%(2X)]andthenmounted.NormalrabbitIgG (1:100;sc-2027:SantaCruzBiotechnology)wasusedasanegativecontrol. Ki-67. ProstatesectionsweredeparaffinizedinLeicaBondDewaxSolution(LeicaMicro- systemsInc.,BuffaloGrove,IL)at72˚C,andthenrehydratedin100%ethanol,followedby3 washesinTris-bufferedsaline.AntigenretrievalwascarriedoutwithNovocastraBondEpitope RetrievalSolution1(citratebuffer,pH6)(AR9961;LeicaMicrosystemsInc.,)for20minutes at100˚C.ThesectionswerestainedwithapredilutedrabbitmonoclonalantibodytoKi-67 (CPRM325AA;BiocareMedicals,Concord,CA)for15minutesatroomtemperature.Theanti- rabbitpoly-HRP-IgGpolymerfromtheBondPolymerRefineDetectionSystem(LeicaMicro- systemsInc.,)wasusedfortheenhancementofthesignal.Thesubstratechromogen,DAB,was usedforthedetectionofthecomplex.SectionswerecounterstainedwithGill’shematoxylin, andprocessedbacktoxylenethroughanincreasingethanolgradient[95%(1X)and100% (2X)],andthenmounted.Tissuefromacaninemastcelltumorwasusedasapositivecontrol. Apoptosis. TerminaldeoxynucleotidyltransferasedUTPnickendlabeling(TUNEL) stainingwasperformedusingtheApoptagPeroxidaseInSituApoptosisDetectionkit(S7100; Millipore,Temecula,CA).ProstatesectionswerebakedinaFisherScientificIsotemp(model 281A)vacuumovenpreheatedto60˚Cfor30minutes.Afterbaking,sectionsweredeparaffi- nizedinxylene,rehydratedthroughagradedethanolseries[100%(2X),95%and70%(1X)] andtreatedwithready-to-useproteinaseK(S302080-2;DakoNorthAmerica,Inc.,Carpin- teria,CA)for15minutesatroomtemperature.Sectionswerewashedwith2changesofdis- tilledwaterfor5minuteseach.Endogenousperoxidaseswereblockedwith3%hydrogen peroxideinphosphatebufferedsaline(PBS,pH7.4),for5minutesandwashedwith2changes ofPBS.Equilibrationbuffercontainingdigoxigenin-conjugatednucleotideswasplaceddi- rectlyontothesectionfor10seconds.Sectionswereincubatedwithterminaldeoxynucleotide transferase(TdT)enzyme(1:15dilution)inahumidifiedchamberat37˚Cfor1hour.Sections werethenincubatedfor10minutesatroomtemperatureinstop-washbuffer,rinsedin3 PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 4/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores changesofPBSfor1minuteeach,andthenincubatedwithanti-digoxigeninconjugatefor30 minutesatroomtemperature.Sectionswerewashedin4changesofPBSfor2minuteseach, andthenincubatedwiththesubstratechromogen,DAB,for3minutes.Sectionswerethen stainedwith0.5%(w/v)methylgreencounterstain,dehydratedthrough100%N-butanol(3X) andxyleneandthenmounted. Biomarkerquantification Aboard-certifiedpathologistidentifiedareasofepitheliumthatwerecomposedofasingle layerofcellsasprostateepithelium;hyperplasticregionsaswheretherewasincreaseddensity ofcellspiledupononeanother;andtumorasdiffusesheetsofcellswithnoorganizationchar- acterizedbyneoplasticcellularcharacteristics,usinganOlympusDP26digitalcamera(Olym- pusAmerica,CenterValley,PA).TheseareaswerescannedusingaPannoramicMidiscanner (3DHistech,Budapest,Hungary)witha20Xobjective,giving2-megapixelresolution.Images werecapturedusingthe3DHistechsoftware.ScannedimageswerethenannotatedusingHalo software(IndicaLaboratory,Coralles,NM).Intumors,areasofviableneoplasticcellsaway fromareasofnecrosisweremeasured.Ki-67andARprotein,andapoptoticDNAfragmenta- tionwerequantifiedusingthedoublestaincytoplasmicandnuclearimmunohistochemistry algorithm(IndicaLaboratory),whichwassettoidentifyasinglepositivenuclearstain.5αR1 and5αR2mRNAwerequantifiedusingthechromogenicRNAinsituhybridizationalgorithm (IndicaLaboratory),whichmeasuresRNAprobesonapercellbasis.Datawerequantifiedfor Ki-67,AR,apoptosis,5αR1and5αR2inprostateepithelium,hyperplasia,andtumorofpros- tatesections.Prostateepitheliumwasdefinedashistologicallynormalprostate.Representative imagesinFig1werecapturedat2Xmagnification. ThetotalpositivecellspertissueareaforKi-67,ARandapoptosiswascalculatedas: Totalpositivecellspertissuearea(μm2)=Totalpositivecells/Tissuearea(μm2) Thetotalprobecopiespertissueareafor5αR1and5αR2mRNAwascalculatedas: Totalprobecopiespertissuearea(μm2)=Totalprobecopies/Totaltissuearea(μm2) Totalpixelspertissueareafor5αR1and5αR2mRNAwasalsocalculated,butthiswasnot usedfordataanalysisduetopoorsensitivity.Immunohistochemistryandinsituhybridization dataarefromasingleexperimentforeachbiomarker. Statisticalanalysis DatawereanalyzedusingANOVAwithFisher’sLeastSignificantDifference(LSD),utilizingSAS 9.4(SASInstituteInc.,Cary,NC)withp<0.05consideredstatisticallysignificant.Celltypeswith n<2wereexcludedfromstatisticalanalysis,andthemodifiedThompsontautechniquewas usedtoeliminateoutliers.IliaclymphnodemetastasesincidencewasanalyzedusingtheKruskal Wallisnon-parametricone-wayANOVA.Correlationbetweenbiomarkersandadjustedprostate severelesionscoreswasanalyzedusingtheSpearmanrankcorrelationcoefficient(r). Results GUweightsandiliaclymphnodemetastases GUweightsin8-,12-,16-,and20-week-oldC57BL/6TRAMPxFVBmicewereincreasedasa functionofage(Table1).Twenty-week-oldmicehadsignificantlyincreasedGUweights PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 5/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores Fig1. Representativestainingfor5α-reductase1(a),5α-reductase2(d),androgenreceptor(g),Ki-67(j)and apoptosis(m)inprostateepitheliumshowingsinglelayerofcells;5α-reductase1(b),5α-reductase2(e), androgenreceptor(h),Ki-67(k)andapoptosis(n)inhyperplasiashowingfocalincreasedcelldensitywith pilingupononeanother;and5α-reductase1(c),5α-reductase2(f),androgenreceptor(i),Ki-67(l)and apoptosis(o)intumorshowingdiffusesheetsofcellswithnoorganizationandcharacterizedbyneoplastic cellularcharacteristics.Staininginprostateandhyperplasiaareshownwithablackarrow. https://doi.org/10.1371/journal.pone.0175874.g001 PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 6/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores Table1. C57BL/6TRAMPxFVBmiceGUweights1andiliaclymphnodemetastasesincidence. Group n GUweights(g) n Lymphnode metastasesincidence(%) 8-weeks 5 0.30±0.01a 2 0(0) 12-weeks 8 0.38±0.02a 8 0(0) 16-weeks 9 0.62±0.07a 9 1(11) 20-weeks 12 3.88±1.09b 12 5(42) 1Dataaremean±SEM;valueswithdifferentlettersarestatisticallydifferent(p<0.05). https://doi.org/10.1371/journal.pone.0175874.t001 versus8-,12-,and16-week-oldmice.Nosignificantdifferenceswereobservedintheincidence ofiliaclymphnodemetastasesbetweengroups(Table1);however,anotabledifferencewas foundinincidencebetween20-(42%)and16-(11%),12-(0%)and8-(0%)week-oldmice. Mostsevereandmostcommonlesionscoresandhistopathological distribution Anterioranddorsallobesrawandadjustedmeanmostsevereandmostcommonlesionscores weresignificantlyincreasedin20-versus8-,12-,and16-week-oldmice(Tables2and3).The dorsallobeadjustedmeanmostcommonlesionscorewassignificantlyincreasedin16-com- paredto12-week-oldmice.Lateralandventrallobesrawandadjustedmeanmostsevereand mostcommonlesionscoresweresignificantlyincreasedin16-and20-versus8-and12-week- oldmice. AnteriorlobeLG-PINasthemostseverelesionwassignificantlyincreasedin8-versus 12-and20-week-oldmice(Table4).LG-PINasthemostseverelesionwassignificantlyin- creasedintheventrallobeof8-comparedto16-and20-week-oldmice.Laterallobemoder- ate-grade(MG)PINasthemostseverelesionwassignificantlyincreasedin8-versus12-week- old,andin8-and12-comparedto16-and20-week-oldmice.MG-PINasthemostsevere lesionwassignificantlyincreasedintheventrallobeof8-versus12-,16-,and20-week-old mice.MG-PINasthemostseverelesionwassignificantlyincreasedintheventrallobeof12- and16-comparedto20-week-oldmice.LaterallobeHG-PINasthemostseverelesionwas significantlyincreasedin12-and16-versus8-and20-week-oldmice.HG-PINasthemost severelesionwassignificantlyincreasedintheventrallobeof12-week-oldmicecomparedto 8-and20-week-oldmice.DorsallobeHG-PINasthemostseverelesionwassignificantly increasedin12-and16-versus20-week-oldmice.PDcarcinomaandprostatecancerasthe mostseverelesionsweresignificantlyincreasedintheanteriorlobeof20-comparedto8-,12-, and16-week-oldmice.DorsallobePDcarcinomaandprostatecancerasthemostsevere lesionsweresignificantlyincreasedin20-versus8-,12-,and16-week-oldmice.PDcarcinoma Table2. Rawandadjustedmeanmostseverelesionscoresfortheanterior,dorsal,lateral,andventralprostatelobes1. Anteriorprostate Dorsalprostate Lateralprostate Ventralprostate Group n Raw Adjusted Raw Adjusted Raw Adjusted Raw Adjusted 8-weeks 5 2.10±0.28a 4.10±0.86a 2.50±0.17a 6.10±0.38a 1.90±0.10a 4.80±0.47a 1.60±0.16a 4.30±0.63a 12-weeks 8 2.56±0.13a 6.13±0.30a 3.00±0.29a 7.38±0.81a 3.00±0.41a 7.50±1.15a 1.56±0.27a 3.56±0.67a 16-weeks 9 2.39±0.31a 5.78±0.95a 3.78±0.42a 10.17±1.39a 5.17±0.50b 14.44±1.62b 4.83±0.59b 13.66±1.87b 20-weeks 12 4.92±0.51b 14.21±1.65b 5.63±0.43b 16.33±1.38b 5.42±0.51b 15.88±1.62b 4.86±0.61b 14.18±1.93b 1Dataaremean±SEM;valueswithdifferentlettersarestatisticallydifferentfromoneanother(p<0.05). https://doi.org/10.1371/journal.pone.0175874.t002 PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 7/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores Table3. Rawandadjustedmeanmostcommonlesionscoresfortheanterior,dorsal,lateral,andventralprostatelobes1. Anteriorprostate Dorsalprostate Lateralprostate Ventralprostate Group n Raw Adjusted Raw Adjusted Raw Adjusted Raw Adjusted 8-weeks 5 1.30±0.21a 2.70±0.58a 2.0a 5.20±0.13a,b 1.50±0.17a 3.70±0.65a 1.60±0.16a 4.30±0.63a 12-weeks 8 1.81±0.14a 4.44±0.41a 2.0a 5.50±0.26a 1.63±0.13a 4.25±0.46a 1.25±0.21a 3.13±0.62a 16-weeks 9 1.83±0.34a 4.56±1.01a 3.22±0.50a 9.39±1.49b 4.11±0.63b 11.94±1.93b 4.22±0.60b 12.28±1.87b 20-weeks 12 4.83±0.53b 14.04±1.69b 4.75±0.50b 14.00±1.55c 5.21±0.52b 15.25±1.67b 4.77±0.63b 14.09±1.96b 1Dataaremean±SEM;valueswithdifferentlettersarestatisticallydifferentfromoneanother(p<0.05). https://doi.org/10.1371/journal.pone.0175874.t003 andprostatecancerasthemostseverelesionsweresignificantlyincreasedinthedorsallobeof 16-comparedto8-and12-week-oldmice.LateralandventrallobesPDcarcinomaandpros- tatecancerasthemostseverelesionsweresignificantlyincreasedin16-and20-versus8-and 12-week-oldmice.Prostatecancerasthemostseverelesionwassignificantlyincreasedinthe lateralandventrallobesof20-comparedto16-week-oldmice. AnteriorlobeLG-PINasthemostcommonlesionwassignificantlyincreasedin8-versus 12-and20-week-oldmice(Table5).MG-PINasthemostcommonlesionwassignificantly increasedintheanteriorlobeof12-comparedto8-,16-,and20-week-oldmice.Dorsallobe MG-PINasthemostcommonlesionwassignificantlyincreasedin8-and12-versus16-and Table4. Histopathologicalanalysis(mostseverelesion)ofindividualprostatelobesin8-,12-,16-,and20-week-oldC57BL/6TRAMPxFVBmice1,2. Prostaticintraepithelialneoplasia Adenocarcinoma Prostatecancer n LG MG HG WD MD PD (WD-PD) Anteriorprostate 8-weeks 5 30%a 30% 40% 0% 0% 0%a 0%a 12-weeks 8 0%b 44% 56% 0% 0% 0%a 0%a 16-weeks 9 17%a,b 50% 28% 0% 0% 6%a 6%a 20-weeks 12 8%b 8% 17% 0% 4% 54%b 58%b Dorsalprostate 8-weeks 5 0% 50% 50%a,b 0% 0% 0%a 0%a 12-weeks 8 0% 25% 69%a 0% 0% 6%a 6%a 16-weeks 9 0% 11% 67%a 0% 0% 22%b 22%b 20-weeks 12 0% 17% 13%b 0% 4% 67%c 71%c Lateralprostate 8-weeks 5 10% 90%a 0%a 0% 0% 0%a 0%a 12-weeks 8 0% 50%b 38%b 0% 0% 13%a 13%b 16-weeks 9 0% 6%c 39%b 0% 0% 56%b 56%c 20-weeks 12 17% 4%c 8%a 0% 4% 67%b 71%d Ventralprostate 8-weeks 5 40%a 60%a 0%a 0% 0% 0%a 0%a 12-weeks 8 13%a,b 44%b 19%b 0% 0% 0%a 0%a 16-weeks 9 0%b 39%b 6%a,b 0% 0% 56%b 56%b 20-weeks 12 8%b 17%c 0%a 0% 4% 54%b 58%c 1Valueswithdifferentlettersarestatisticallydifferentfromoneanother(p<0.05). 2LG=low-grade,MG=moderate-grade,HG=high-grade,PIN=prostaticintraepithelialneoplasia,WD=well-differentiated,MD=moderately differentiated,PD=poorlydifferentiated. https://doi.org/10.1371/journal.pone.0175874.t004 PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 8/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores Table5. Histopathologicalanalysis(mostcommonlesion)ofindividualprostatelobesin8-,12-,16-,and20-week-oldC57BL/6TRAMPxFVB mice1,2. Prostaticintraepithelialneoplasia Adenocarcinoma Prostatecancer n LG MG HG WD MD PD (WD-PD) Anteriorprostate 8-weeks 5 80%a 10%a 10% 0% 0% 0%a 0%a 12-weeks 8 25%b,c 69%b 6% 0% 0% 0%a 0%a 16-weeks 9 50%a,b 39%a 6% 0% 0% 6%a 6%a 20-weeks 12 13%c 21%a 8% 0% 4% 54%b 58%b Dorsalprostate 8-weeks 5 0% 100%a 0%a 0% 0% 0%a 0%a 12-weeks 8 0% 100%a 0%a 0% 0% 0%a 0%a 16-weeks 9 0% 67%b 11%b 0% 0% 22%b 22%a 20-weeks 12 0% 38%b 8%c 0% 4% 50%c 54%b Lateralprostate 8-weeks 5 50% 50% 0% 0% 0% 0%a 0%a 12-weeks 8 38% 63% 0% 0% 0% 0%a 0%a 16-weeks 9 11% 44% 0% 0% 0% 44%b 44%b 20-weeks 12 17% 8% 8% 0% 4% 63%c 67%c Ventralprostate 8-weeks 5 40% 60%a 0% 0% 0% 0%a 0%a 12-weeks 8 25% 50%a 0% 0% 0% 0%a 0%a 16-weeks 9 0% 56%a 0% 0% 0% 44%b 44%b 20-weeks 12 17% 8%b 0% 0% 4% 54%c 58%c 1Valueswithdifferentlettersarestatisticallydifferentfromoneanother(p<0.05). 2LG=low-grade,MG=moderate-grade,HG=high-grade,PIN=prostaticintraepithelialneoplasia,WD=well-differentiated,MD=moderately differentiated,PD=poorlydifferentiated. https://doi.org/10.1371/journal.pone.0175874.t005 20-week-oldmice.VentrallobeMG-PINasthemostcommonlesionwassignificantlyin- creasedin8-,12-,and16-comparedto20-week-oldmice.DorsallobeHG-PINasthemost commonlesionwassignificantlyincreasedin16-and20-versus8-and12-week-oldmice. HG-PINasthemostcommonlesionwassignificantlyincreasedinthedorsallobeof16-com- paredto20-week-oldmice.AnterioranddorsallobesPDcarcinomaandprostatecanceras themostcommonlesionsweresignificantlyincreasedin20-versus8-,12-and16-week-old mice.PDcarcinomaasthemostcommonlesionwassignificantlyincreasedinthedorsallobe of20-comparedto16-week-oldmice.PDcarcinomaandprostatecancerasthemostcommon lesionsweresignificantlyincreasedinthelateralandventrallobesof20-versus16-week-old mice.LateralandventrallobesPDcarcinomaandprostatecancerasthemostcommonlesions weresignificantlyincreasedin16-and20-comparedto8-and12-week-oldmice. 5αR1,5αR2,AR,proliferation,andapoptosis Prostateepithelium,hyperplasiaandtumorrepresentativestainingsfor5αR1areshowninFig 1A,1Band1C,respectively.Prostateepithelium,hyperplasiaandtumorrepresentativestain- ingsfor5αR2areshowninFig1D,1Eand1F,respectively.Therewasnosignificantdifference in5αR1and5αR2inthecelltypeswithinandbetweengroups(Tables6and7).5αR1waspre- dominantlyexpressedinprostateepitheliumversusstromawhile5αR2washighlyexpressed inbothprostateepitheliumandstroma.Prostateepithelium,hyperplasiaandtumorARrepre- sentativestainingsareshowninFig1G,1Hand1I,respectively.Therewasasignificant PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 9/15 5α-reductase1levelsarepositivelycorrelatedwithmostseverelesionscores Table6. 5α-reductase1expressionin8-,12-,16-,and20-week-oldC57BL/6TRAMPxFVBmice. Thevaluesarethemeantotal5α-reductase1probe copiespertissuearea(μm2)±SEMinprostateepithelium,hyperplasiaortumor. 5α-reductase1 Group n Prostateepithelium n Hyperplasia n Tumor 8-weeks 5 5.8±2.5 5 5.4±1.1 - — 12-weeks 4 18.7±8.7 5 10.5±4.1 2 16.8±12.1 16-weeks 5 15.1±5.3 5 6.7±3.5 2 15.7±5.1 20-weeks 2 22.4±9.5 2 13.5±5.6 4 15.8±4.1 p<0.05vs.prostateepithelium,hyperplasiaandtumorwithinandbetweengroups.Dataaremultipliedby1000. https://doi.org/10.1371/journal.pone.0175874.t006 increaseinARexpressioninhyperplasiacomparedtoprostateepitheliumandtumorof 16-week-oldmice(Table8).TherewasasignificantdecreaseinARexpressionintumorversus prostateepitheliumandhyperplasiaof20-week-oldmice.Prostateepithelium,hyperplasiaand tumorKi-67representativestainingsareshowninFig1J,1Kand1L,respectively.Therewasa significantincreaseinKi-67expressioninprostateepitheliumandhyperplasiaof8-compared to16-and20-week-oldmice(Table9).TherewasasignificantincreaseinKi-67expressionin prostateepitheliumof12-versus16-week-oldmice.TherewasasignificantincreaseinKi-67 expressioninhyperplasiacomparedtoprostateepitheliumandtumorof20-week-oldmice. Prostateepithelium,hyperplasiaandtumorapoptosisrepresentativestainingsareshownin Fig1M,1Nand1O,respectively.Therewasnosignificantdifferenceinapoptosisinthecell typeswithinandbetweengroups(Table10). Biomarkercorrelationwithadjustedprostateseverelesionscores Onlyonesignificantcorrelationbetweenbiomarkersandadjustedprostateseverelesionscores wasidentified.Prostate5αR1levelswerepositivelycorrelatedwithadjustedprostatemost severelesionscores(Fig2).Correlationbetween5αR1inprostateandadjustedprostatesevere lesionscoreswascomparedin8-,12-,16-,and20-week-oldmiceandfoundtohaveasimilar trendinallgroups,thusagedidnotappeartoimpactthiscorrelation.Adjustedprostatesevere lesionscoreswasusedbecauseitcombineslesionseveritywithanindicationofitsdistribution withinalobe[22]. Discussion Therawandadjusted,meanmostseverelesionscoreswereslightlyincreasedin20-week-old micecomparedto20-week-oldcontrolC57BL/6TRAMPxFVBmiceinourpreviousstudy [23],whichmaysuggestthatinthisstudy,lesionsweremoresevereorprogressingfaster. Giventhatthisstudywasconductedatthesametimeusinglittermatesofthatstudy,this Table7. 5α-reductase2expressionin8-,12-,16-,and20-week-oldC57BL/6TRAMPxFVBmice. Thevaluesarethemeantotal5α-reductase2probe copiespertissuearea(μm2)±SEMinprostateepithelium,hyperplasiaortumor. 5α-reductase2 Group n Prostateepithelium n Hyperplasia n Tumor 8-weeks 5 9.0±4.7 5 3.8±1.3 - — 12-weeks 5 12.2±5.3 5 9.0±4.6 2 12.7±10.6 16-weeks 4 7.5±2.6 4 6.9±3.6 2 0.7 20-weeks 1 17.7 1 1.8 3 4.1±1.6 p<0.05vs.prostateepithelium,hyperplasiaandtumorwithinandbetweengroups.Dataaremultipliedby1000. https://doi.org/10.1371/journal.pone.0175874.t007 PLOSONE|https://doi.org/10.1371/journal.pone.0175874 May11,2017 10/15
Description: